Myocardial performance index in pediatric patients after cardiac transplantation

Area of Science:

• Cardiology
• Pediatric Cardiology
• Transplantation Medicine

Background:

• Myocardial Performance Index (MPI) is a recognized metric for assessing ventricular function.
• Cardiac transplantation is a life-saving procedure for pediatric end-stage heart failure.
• Evaluating post-transplant ventricular performance is crucial for long-term outcomes.

Purpose of the Study:

• To determine Myocardial Performance Index (MPI) values in pediatric patients following cardiac transplantation.
• To compare MPI in transplanted children without rejection to a healthy pediatric control group.

Main Methods:

• MPI was measured in 41 pediatric cardiac transplant recipients.
• MPI was also measured in 31 pediatric control subjects.
• Patients were confirmed to have no evidence of microscopic endomyocardial rejection.

Main Results:

• The transplant group exhibited a significantly higher MPI (0.41 ± 0.12) compared to the control group (0.31 ± 0.09; P = .0003).
• Elevated isovolumic relaxation time and isovolumic relaxation time/ejection time ratios were observed in the transplant group.
• Isovolumic contraction time and its ratio to ejection time were comparable between groups.

Conclusions:

• Pediatric cardiac transplant recipients without rejection demonstrate elevated MPI compared to controls.
• The increased MPI suggests impaired diastolic function in these patients.
• MPI may serve as a valuable non-invasive tool for monitoring ventricular health post-pediatric cardiac transplantation.